Obtaining informed consent for clinical tumor and germline exome sequencing of newly diagnosed childhood cancer patients.
about
Pediatric solid tumor genomics and developmental pliancyIs Whole-Exome Sequencing an Ethically Disruptive Technology? Perspectives of Pediatric Oncologists and Parents of Pediatric Patients With Solid Tumors.Renal cell carcinoma harboring somatic TSC2 mutations in a child with methylmalonic acidemiaCurrent state of pediatric sarcoma biology and opportunities for future discovery: A report from the sarcoma translational research workshop.Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine.Parent and public interest in whole-genome sequencingCancer susceptibility syndromes in children in the area of broad clinical use of massive parallel sequencing.Pediatric Cancer Genetics Research and an Evolving Preventive Ethics Approach for Return of Results after Death of the Subject.Recurrent internal tandem duplications of BCOR in clear cell sarcoma of the kidney.Integrated tumor and germline whole-exome sequencing identifies mutations in MAPK and PI3K pathway genes in an adolescent with rosette-forming glioneuronal tumor of the fourth ventricle.Recommendations for the integration of genomics into clinical practiceCancer diagnostics: The journey from histomorphology to molecular profiling.Genome-Wide Sequencing for Prenatal Detection of Fetal Single-Gene Disorders.How do clinical genetics consent forms address the familial approach to confidentiality and incidental findings? A mixed-methods study.Novel patient-derived xenograft and cell line models for therapeutic testing of pediatric liver cancer.Precision medicine in pediatric oncology: Lessons learned and next steps.Patient/parent perspectives on genomic tumor profiling of pediatric solid tumors: The Individualized Cancer Therapy (iCat) experience.Overcoming challenges to meaningful informed consent for whole genome sequencing in pediatric cancer research.Ethical considerations surrounding germline next-generation sequencing of children with cancer.Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors.The American Society of Pediatric Hematology/Oncology workforce assessment: Part 2-Implications for fellowship training.Patient understanding of, satisfaction with, and perceived utility of whole-genome sequencing: findings from the MedSeq Project.A Research Agenda for Communication Scholars in the Precision Medicine Era.Reasons for Declining Preconception Expanded Carrier Screening Using Genome Sequencing.Why Patients Decline Genomic Sequencing Studies: Experiences from the CSER Consortium.Pediatric Whole Exome Sequencing: an Assessment of Parents' Perceived and Actual Understanding.Experiences with obtaining informed consent for genomic sequencing.Portero versus portador: Spanish interpretation of genomic terminology during whole exome sequencing results disclosure.
P2860
Q27023560-006BC0E3-6DE4-4A54-B428-4C4699B2F929Q30798291-E7C40A7B-1E98-4CD9-8F08-84568B5AA092Q33792426-0C2F8163-74E3-499F-8418-72DBC186EE51Q33872384-98929795-8FF5-499B-8DDA-1DE9BB528C32Q34526631-E3675897-5EB0-47B5-85CE-93D7EF434661Q35528249-91EFDC60-216D-443C-B4D9-2F5523633B10Q35894536-C9A71AA0-F378-4834-AC06-58D7676738BAQ36197118-C78519C6-3928-41D8-A71C-B99B7A8E2C1DQ36320478-60DE1A14-A7AC-43CF-AC1F-507ADD8E206EQ37212868-AAA3B5E4-443D-425E-86FF-77571941B331Q38376302-C7F89EA6-4C32-4056-8959-2C6FC8B8526CQ38559476-EDA0E13A-D03A-451A-B807-513CDE42B951Q38562550-BCCEEB3A-BE15-46B1-AB57-32382A0FEEDAQ38730932-81BD4515-266F-415A-ABEF-6A8FDE83529EQ38775165-CFDBF05E-3CCD-4D81-86CC-9380FB655437Q38810911-FF561FE8-4D23-47C2-91F6-157D3CE8430BQ38840660-EAB4F28A-8B33-4628-9901-07B8A44E4F56Q39022681-E836789A-EE24-4073-AD03-D407660BA523Q39235246-19244FD8-301A-4711-B896-0D39C25E4CCCQ41783629-355DD113-1223-4357-88D4-315A834CC972Q46362700-D5010782-A2DA-488D-A3D4-0BC0E56D990DQ47275552-64C1CF3E-1500-41EC-AA33-A40AB90308C9Q49685560-2438B260-C504-42AC-BFF2-1BE03896466BQ50791686-BF2C386B-683C-4C38-8C61-6E98BD7A39A8Q52677797-9E23CBDE-1A01-466A-A455-A4CA7019965CQ52775606-E4DFFA75-7604-4432-BF57-BB7D7A520380Q54858926-196E0BCA-D990-461E-9758-0B84E896B849Q58860481-57D49944-77FE-4BDB-B058-4CD9E7568ED6
P2860
Obtaining informed consent for clinical tumor and germline exome sequencing of newly diagnosed childhood cancer patients.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Obtaining informed consent for ...... sed childhood cancer patients.
@ast
Obtaining informed consent for ...... sed childhood cancer patients.
@en
type
label
Obtaining informed consent for ...... sed childhood cancer patients.
@ast
Obtaining informed consent for ...... sed childhood cancer patients.
@en
prefLabel
Obtaining informed consent for ...... sed childhood cancer patients.
@ast
Obtaining informed consent for ...... sed childhood cancer patients.
@en
P2093
P2860
P1433
P1476
Obtaining informed consent for ...... sed childhood cancer patients.
@en
P2093
Christine M Eng
D Williams Parsons
Katie Bergstrom
Murali M Chintagumpala
Richard A Gibbs
Robin A Kerstein
Sarah Scollon
Sharon E Plon
Stacey L Berg
Susan G Hilsenbeck
P2860
P2888
P356
10.1186/S13073-014-0069-3
P577
2014-09-17T00:00:00Z
P5875
P6179
1028466588